PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Pentosan polysulfate sodium
Presentation Product Chemical substance Chapter Items dispensed
Pentosan polysulfate sodium 100mg capsules
0208020I0AAAGAG
Pentosan polysulfate sodium (Oral) Pentosan polysulfate sodium Cardiovascular System 268
Elmiron 100mg capsules (Consilient Health)
0208020I0BEACAG
Elmiron Pentosan polysulfate sodium Cardiovascular System 154
Elmiron 100mg capsules (Sovereign Medical)
0208020I0BEADAG
Elmiron Pentosan polysulfate sodium Cardiovascular System 1
Elmiron 100mg capsules (Imported)
0208020I0BEABAG
Elmiron Pentosan polysulfate sodium Cardiovascular System No data available
Elmiron 100mg capsules (Teva)
0208020I0BEAAAG
Elmiron Pentosan polysulfate sodium Cardiovascular System No data available
Fibrase 50mg capsules
0208020I0BBAAAB
Fibrase (Oral) Pentosan polysulfate sodium Cardiovascular System No data available
Pentosan polysulfate sodium 50mg capsules
0208020I0AAABAB
Pentosan polysulfate sodium (Oral) Pentosan polysulfate sodium Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.